|
It was reported that following a left eye (os) cataract plus trabecular microbypass stent system procedure, the patient presented approximately one (1) month postop with rebound iritis described as "mild and non-serious", which was resolved with resumption of medications.Any omitted information was not available at the time of report.
|
|
Additional information: the device was not available; therefore, product testing on the actual device could not be performed.The device history record review of the manufacturing lot, including relevant sterilization records, was performed and there were no non-conformities found to be related to the reported event.A review of the device labeling was completed.Iritis is identified in the labeling as a known inherent risk of trabecular micro-bypass stent procedure.The ifu adequately provides instructions for stent implantation, precautions, and warnings for the proper use and handling of the device.An adverse event appears to have occurred, but does not appear to have been a problem with the device or the way it was used.Iritis is an established risk associated with use of the device, which is clearly specified in the product's labeling.Based on the information received, the root cause of the reported event could not be conclusively identified.Mfr# reference: (b)(4).
|